[1] |
PAN Yufan, NIU Xuping.
Update of diseases associated with bullous pemphigoid
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(2): 145-150.
|
[2] |
CHEN Liuxin, CAI Yanxia, LIU Yaqin, YANG Yanping, XIE Yingxia, DENG Shiyin, LUO Yaqi.
Bullous scabies: 3 cases report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(7): 474-479.
|
[3] |
ZHENG Chunzhi, ZHANG Minkuo, SAI Wenwen, CAO Yuanyuan, ZHANG Zhaoxia, PAN Futang, YANG Baoqi, LIU Hong.
Bullous pemphigoid occurred after long-term treatment with camrelizumab in a patient with oesophageal cancer: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(6): 422-424.
|
[4] |
WU Qian, JIANG Fuqiong, YOU Shuqiong, WANG Yuan, WU Yongzhuo.
Update of the treatment of bullous pemphigoid based on disease-modifying
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(5): 371-376.
|
[5] |
DONG Feifan, LIU Yongxia, TIAN Hongqing.
Bullous pemphigoid with erosions and ulceras on genital as the first symptom: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(4): 255-258.
|
[6] |
HAN Junya, WU Weiwei, HE Xiaojun, ZHU Wenwen, FANG Xianfeng.
Related factors analysis and prediction model establishment of malignant tumor in patients with bullous pemphigoid
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 157-162.
|
[7] |
CHANG Jiayu, QI Miao, WANG Yimin, LI Yongxi, SHI Tongxin.
Bullous pemphigoid occurred in a patient with severe plaque psoriasis treated with secukinumab: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 199-201.
|
[8] |
SHAO Yuling, WANG Na, YU Changping, LIU Yongxia, ZHOU Guizhi, YANG Qing.
Nonbullous pemphigoid: four cases report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(12): 855-858.
|
[9] |
CAO Shan, LIU Hong, ZHANG Furen.
Update of nonbullous pemphigoid
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(12): 899-902.
|
[10] |
LI Yanbo, ZHU Junrong, WANG Shangshang.
Bullous pemphigoid secondary to atopic dermatitis: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(11): 809-811.
|
[11] |
ZHANG Ruixia, TANG Junting, HE Angran.
Glucocorticoid combined with dupilumab in the treatment of bullous pemphigoid complicated with verruca plana: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(10): 727-729.
|
[12] |
ZHOU Yuxi, LI Jishu, WANG Jinqiu, LI Xiaohong, FENG Chenchen, ZHOU Xingli, LI Wei.
Efficacy and safety of dupilumab in the treatment of bullous pemphigoid for 16 weeks: a retrospective study
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(1): 21-25.
|
[13] |
JIA Fengming, FANG Meng, LIU Yongxia, LIU Hong.
Dupilumab alone successfully treated an elderly patient with bullous pemphigoid
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(9): 661-663.
|
[14] |
ZHANG Kun, CHEN Lixiu.
Bullous pemphigoid with positive pemphigus antibody in erythroderma: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(8): 606-608.
|
[15] |
ZHAO Dandan, ZHEN Li.
Analysis of the prognostic factors of bullous pemphigoid based on random forest model
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(5): 338-343.
|